Info: 90 Veg. Capsules
Tradition has it that Stinging Nettle has been used since the days of Caesar for a variety of purposes, mostly to reduce inflammation (including gout), and also for urinary issues.
Info: 90 Veg. Capsules
Tradition has it that Stinging Nettle has been used since the days of Caesar for a variety of purposes, mostly to reduce inflammation (including gout), and also for urinary issues.
Product Notes:
Modern research has indicated that the roots in particular can help relieve the symptoms of an enlarged prostate, such as frequent urination and weak urinary flow (but it will not cure or reverse the enlargement itself). NOW's Stinging Nettle Root Extract has been concentrated and standardized to the highest European standards, to help those in the early stages of benign prostatic hyperplasia (BPH).
Ingredients:
Each capsule contains:
250 mg Stinging Nettle Root (Urtica dioica L.), Equivalent to 3000 mg dried root, Standardized to contain 0.80% Sterols as beta sitosterol
Non-medicinal ingredients: White Rice Flour, Vegetable Capsule (hypromellose, water), Magnesium Stearate (vegetable source), Silica.
NOW Foods Stinging Nettle contains no: sugar, salt, yeast, wheat, gluten, corn, soy, milk, egg, shellfish or preservatives. Vegetarian/Vegan Product.
Suggested Usage:
Adults: Take 1 capsule 3 times daily. Store in a cool, dry place.
Warnings:
Do not use stinging nettle if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen.
Health Canada Natural Product Number: 80018890.
Supporting Science:
Konrad, L., Muller, H.H., Lenz, C. et al. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med 2000.
Schneider, T. and Rübben, H. Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months. [Article in German] Urologe [A]. 2004.
Sökeland, J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU International. 2000.